Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$730M |
| 3 |
Apple
AAPL
|
+$706M |
| 4 |
Walmart Inc
WMT
|
+$391M |
| 5 |
Alibaba
BABA
|
+$381M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 2 |
Hilton Worldwide
HLT
|
+$613M |
| 3 |
British American Tobacco
BTI
|
+$491M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$475M |
| 5 |
AABA
Altaba Inc
AABA
|
+$418M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.23% |
| 2 | Technology | 10.01% |
| 3 | Healthcare | 8.22% |
| 4 | Consumer Discretionary | 7.8% |
| 5 | Industrials | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
PUT
PACCAR
PCAR
$69.8B
| $1.26M | ﹤0.01% |
26,550
-2,850
| -10% | -$135K |
|
|
ESV
4102
CALL
DELISTED
Ensco Rowan plc
ESV
| $1.26M | ﹤0.01% |
53,200
-10,775
| -17% | -$239K |
|
|
GENZ
4103
VanEck Digital Native Economy ETF
GENZ
$16.8M
| $1.25M | ﹤0.01% |
+26,913
| New | +$1.19M |
|
|
BLCM
4104
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.25M | ﹤0.01% |
14,886
+1,926
| +15% | +$189K |
|
|
OXLC
4105
Oxford Lane Capital
OXLC
$894M
| $1.24M | ﹤0.01% |
+24,704
| New | +$1.27M |
|
4106
PUT
Fossil Group
FOSL
$293M
| $1.24M | ﹤0.01% |
159,400
+65,000
| +69% | +$503K |
|
4107
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.56B
| $1.24M | ﹤0.01% |
39,905
+4,300
| +12% | +$132K |
|
4108
CALL
Ultragenyx Pharmaceutical
RARE
$2.45B
| $1.24M | ﹤0.01% |
26,700
-12,800
| -32% | -$628K |
|
|
4109
PUT
Ultragenyx Pharmaceutical
RARE
$2.45B
| $1.24M | ﹤0.01% |
26,700
-53,300
| -67% | -$2.61M |
|
4110
MacroGenics
MGNX
$235M
| $1.24M | ﹤0.01% |
65,108
+3,841
| +6% | +$71.7K |
|
|
WLL
4111
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $1.24M | ﹤0.01% |
623
-220
| -26% | -$386K |
|
|
ATRI
4112
DELISTED
Atrion Corp
ATRI
| $1.24M | ﹤0.01% |
1,959
-3,400
| -63% | -$2.22M |
|
|
NTUS
4113
PUT
DELISTED
Natus Medical Inc
NTUS
| $1.23M | ﹤0.01% |
+32,300
| New | +$1.29M |
|
|
MTL
4114
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $1.23M | ﹤0.01% |
234,763
+16,720
| +8% | +$80.6K |
|
4115
Glaukos
GKOS
$9.83B
| $1.23M | ﹤0.01% |
48,066
-65,612
| -58% | -$1.95M |
|
|
VIAB
4116
CALL
DELISTED
Viacom Inc. Class B
VIAB
| $1.23M | ﹤0.01% |
40,000
-270,800
| -87% | -$7.35M |
|
4117
PUT
ProShares UltraShort S&P500
SDS
$415M
| $1.23M | ﹤0.01% |
1,197
-801
| -40% | -$873K |
|
4118
PUT
VF Corp
VFC
$5.63B
| $1.23M | ﹤0.01% |
17,629
-105,457
| -86% | -$6.97M |
|
4119
PUT
Brinker International
EAT
$9.17B
| $1.22M | ﹤0.01% |
+31,500
| New | +$1.09M |
|
4120
Bank of N.T. Butterfield & Son
NTB
$2.43B
| $1.22M | ﹤0.01% |
33,721
-96,309
| -74% | -$3.58M |
|
4121
Arcos Dorados Holdings
ARCO
$1.72B
| $1.22M | ﹤0.01% |
121,332
+47,076
| +63% | +$461K |
|
4122
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $1.22M | ﹤0.01% |
10,957
-2,753
| -20% | -$298K |
|
|
ENZ
4123
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.22M | ﹤0.01% |
149,854
+7,231
| +5% | +$69.1K |
|
4124
Coeur Mining
CDE
$15.4B
| $1.22M | ﹤0.01% |
162,235
-247,754
| -60% | -$1.94M |
|
4125
Seaboard Corp
SEB
$4.23B
| $1.22M | ﹤0.01% |
276
-38
| -12% | -$165K |
|
Similar funds
Goldman Sachs's Q4 2017 Portfolio in Review
As of Q4 2017, Goldman Sachs held 7,002 positions worth $418B, up 2.4% from $408B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q4 2017 filing shows 382 new, 2,273 increased, 3,347 reduced and 699 closed positions. Its largest new stake was Golden Entertainment: 4,030,636 shares worth $132M. The largest sale was iShares Russell 2000 ETF, an estimated $655M.
By sector, the portfolio is most concentrated in Financials at 10% of assets, up from 9.6% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q4 2017 buy was Golden Entertainment: 4,030,636 shares worth $132M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.61B increase.
- Goldman Sachs's biggest Q4 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $655M.
- Goldman Sachs fully exited CR Bard Inc. in Q4 2017, selling an estimated $368M.
- Goldman Sachs's ten largest holdings make up 16% of its $418B portfolio in Q4 2017.
- Goldman Sachs opened 382 new positions and closed 699 in Q4 2017.
- Goldman Sachs's portfolio value rose 2.4% quarter-over-quarter to $418B.
Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.